Search This Blog

Apr 21, 2010

Vikas WSP Ltd - 519307

 

 

Name of Company

Vikas WSP Ltd

BSE Code

519307

NSE Code

 

ICICI Code

Established

My Take

Dislike

Headquarters

Bhiwani

Promoters

 

Story

Operator driven useless stock. Don't waste time checking its annual report. This company has no proper business of its own

Sector

Chemicals

Sub-sector

Website

http://www.vikasvegan.com/

Positives

Negatives

Lot of insider trading. These companies just give small dividends and great results for one or 2 years to seem like wonderful companies. Just avoid.

Peers

 

 

Teledata Informatics Ltd - 532358

 

 

Name of Company

Teledata Informatics Ltd

BSE Code

532358

NSE Code

 

ICICI Code

Established

My Take

Dislike

Headquarters

Velachery, Chennai

Promoters

 

Story

This is a fraud company. Promoters are just trying to make the best money from listing, delisting, insider trading and stock split etc. Forget this and go for better IT companies

Sector

IT

Sub-sector

IT services

Website

http://www.teledatain.com/

Positives

Negatives

Peers

 

 

Silverline Technology - 500389



Name of Company
Silverline Technologies
BSE Code
500389
NSE Code

ICICI Code
Established
1992
My Take
Dislike
Headquarters
Mumbai
Promoters

Story
BPO and IT company. Listed in NSE, BSE and NASDAQ. During 2007, share prices at nasdaq were $45, now at $0.6 with no trading volume.
Sector
IT
Sub-sector
BPO and IT
Website
http://www.silverline.com
Positives
Negatives
Promoter holding says 0.01%. keep out. The promoters even tried to reverse-split
Peers

Nandan Exim - 532641

 

 

Name of Company

Nandan Exim

BSE Code

532641

NSE Code

 

ICICI Code

Established

My Take

Dislike

Headquarters

Ahmedabad

Promoters

Chiripal enterprises and Chiripal family

Story

Manufacturing facilities in Ahmedabad.

Sector

Textiles

Sub-sector

Cotton dyed fabric

Website

http://www.chiripalgroup.com/nandanexim.php

http://www.nandanexim.com/

Positives

Negatives

No proper website as well. Real penny stock with year high and low at 3.23 and 1.05. These stocks are easily moved up and down by operators. Don't buy if you are not an operator yourself. Too much equity – Dec09 qtrly P/E = 4.17 Cr/45.5 Cr=0.09. P/E is too high. In days when all textile players are avoided, this is a strict no-no.

Peers

 Indo Count Ind, Futura poly, Alok inds

 

Himachal Futuristic Communications Ltd (HFCL) - 500183

 

 

Name of Company

Himachal Futuristic Communications Ltd (HFCL)

BSE Code

500183

NSE Code

HIMACHLFUT

ICICI Code

Established

1987

My Take

Dislike

Headquarters

Solan

Promoters

 

Story

Manufacturing plant in Solan and Goa.

Sector

Manufacturing

Sub-sector

Telecom cables (OFC), transmission equipment

Website

http://www.hfcl.com/

Positives

Negatives

Consistently loss making company with no future hopes of making a profit.

Peers

 

 

Shilpa Medicare - 530549



Name of Company
Shilpa Medicare
BSE Code
530549
NSE Code

ICICI Code
Established
1987
My Take
Wait n watch
Headquarters
Raichur, Karnataka
Promoters
Vishnukath Butada and family, Inani family
Story
Manufactures oncology API's, general API's and drug intermediaries. It is working on product development as well. The Company is already exporting to USA, Canada, Australia, Japan and European Countries viz., Germany, Switzerland, Netherlands, Belgium, Spain, Greece, Cyprus, Italy, United Kingdom etc., South American Countries like Mexico, Brazil, Columbia etc., African Countries like Kenya, Nigeria and West Indies etc., Asian Countries like Singapore, Taiwan, China, Malaysia, Thailand and closer to home to Iran, Egypt, Pakistan and Bangladesh.
Sector
Pharma
Sub-sector
API's with focus in oncology (cancer)
Website
Positives
Rapidly increasing revenue and profits. ICICI has invested in this counter. NPM is 20% in qtrs jun09 to dec09. Around 10% annually in previous years. Revenues rose from 37 to 135 crores from FY05 to FY09. Expected revenues for FY10 is >200 Crores. Expected profit is 45-50 Crores. New JV with Italian company to setup manufacturing facility for its products.
Negatives
52 week low is at 47. D/E ratio is 1.43 at end FY09. Lot of SAST and insider trading mentioned on BSE. 75% of its revenues are derived from exports. At all time high of 362, P/E is 23 - too high for a small company. market cap is 750 Crores while expected FY10 revenues are 200 crores. Some of the oncology products are slated for expiry.
Peers
 Solvay Pharma, Sequent Scientific

IOL Chemicals and Pharmaceuticals (formerly Industrial Organics) - 524164



Name of Company
IOL Chemicals and Pharmaceuticals (formerly Industrial Organics)
BSE Code
524164
NSE Code
Not traded
ICICI Code
Established
1986
My Take
Like
Headquarters
Ludhiana, Punjab
Promoters
CMD-Varinder Gupta,
Story
One of the largest manufacturers of APIs and specialty chemicals with presence in over 52 countries across the world, IOLCP manufactures and supplies APIs and specialty chemicals for use in various pharmaceutical, Textile, Packaging, Lamination, Pesticides, Food processing applications. Its product portfolio includes APIs, lbuprofen, specialty chemicals such as ethyl acetate, acetic anhydride, Iso Butyl Benzene, Mono Chloro Acetic Acid and Acetyl Chloride and bulk chemicals such as Glacial Acetic acid. IOLCP is currently in a phase of expansion with an investment outlay of Rs. 256 Crore which would include capacity expansion for its various product lines, forward and backward integration and increase in cogeneration of power. IOLCPs overseas customers are spread out across several countries including Argentina, Brazil, China, Denmark, Germany, Singapore, Hong Kong, Kenya, Malaysia, Peru, Egypt and many others. The company has strong business relationships with a number of prestigious clients such as Ranbaxy Labs, Aurobindo Pharma, Dr Reddy, DS Group, CIPLA, Uflex Industries, ITC Limited, ICI Paints, Asian Paints, Pidilite, Rallis India, Hindustan Polymide, Gujarat Super Phosphate, Avon Organics Ltd. etc.
Sector
Pharma
Sub-sector
Chemicals and API's for pharma
Website
http://www.industrialorganics.com/
Positives
Company has reported excellent results for Q3 with PAT of 6.38 crs. as against 86 lakhs in corresponding quarters of previous year. Company has recently commenced manufacturing operations at its new Plant of IBB with capacity of 6600 TPA which is R/M for its Pharma Product 'Ibuprofen.IOL is second company in India to produce IBB.Production capacity of Ibuprofen has also been increased to 3600 TPA.IOL has also started production of MCA with 7200 TPA capacity and Acetyl Chloride with 5200 TPA capacity. These are also R/M for Ibuprofen.With completion of backward integration and expansion (as company has cogen power also), IOL is emerging as an efficient chemical-cum-pharma company in India and should report excellent results in coming quarters.At present prices of 66 its quoting at just 5.5 times its forward earnings. 52 week high is 108. >50% promoter share holding.
Negatives
CARE BBB rating, OPM's ranging from 1.5% to 7% (average is 4%).
Peers
 Ester Industries, English Indian, Jindal poly

LinkWithin

Related Posts Plugin for WordPress, Blogger...